- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Prehospital High-Sensitivity Cardiac Troponin Test can rule out MI
The last decade has seen an increased focus on diagnostic assessment with troponins outside of hospitals. Point-of-care (POC) troponin assays, used in general practice or by emergency medical services (EMS), are useful in identifying high-risk patients.
In a recent study, researchers have found that point-of-care high-sensitivity cardiac troponin (hs-cTn) assays have the potential to safely rule out MI in the prehospital setting, thereby avoiding unnecessary ambulance rides. The study findings were published in the Journal of American College of Cardiology on November 29, 2021.
Patients presenting with acute chest pain outside of hospitals represent a diagnostic challenge. Presently, most hs-cTn assays are conducted in hospital laboratories to help to diagnose and rule out MI, with newer accelerated algorithms enabling patients to be triaged within hours. Dr Jamie G. Cooper and his team postulated a hypothesis what if patients were able to have their blood drawn and assessed before they even reach the hospital, potentially allowing them to stay home?
Therefore, they conducted a prespecified secondary analysis of the ACCESS study, in which patients with suspected ACS were assessed in ambulances fitted with Samsung LABGEOIB10 point-of-care analyzers (Samsung) between 2014 and 2018.
Key Findings of the study:
- Among 966 patients with a prehospital hs-cTn measurement, the researchers identified 44% had known ischemic heart disease and 19% had a subsequent MI or cardiac death within the next 30 days. The median hs-cTnI concentration was 4.0 ng/L.
- Overall, they noted that 28.9% of patients had hs-cTnI concentration below the laboratory assay's limit of detection of < 2 ng/L, with a sensitivity of 97.3% and a negative predictive value of 98.2%.
- They also noted that more than half of patients (55.4%) had levels below the rule out threshold of < 5 ng/L, with a sensitivity of 88.5% and negative predictive value of 96.1%.
- They observed similar findings in subgroups with normal ECG and subgroups stratified by age, sex, and smoking status.
- They noted that the negative predictive value was even higher in patients with a normal ECG without known ischemic heart disease (98.3%) who presented within 3 hours of symptom onset (98.8%).
The authors concluded, "Our findings demonstrate how hs-cTn testing might be applied to risk-stratify patients in the prehospital setting".
For further information:
Cooper JG, Ferguson J, Donaldson LA. Could high-sensitivity cardiac troponin testing rule out acute myocardial infarction in the prehospital setting?_ J Am Coll Cardiol_. 2021;78:2392-1294.
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751